Christoffer Vannas is a PhD student at the Institute of Biomedicine at Gothenburg University. He obtained his MD from Gothenburg University in 2015 and is currently doing a residency in oncology at Sahlgrenska University hospital. He is active as a teacher at the pathology and oncology courses for students at the medical program and the dentist program at Gothenburg University. His current research is focused on signalling pathways and targeted therapy in sarcomas. He is also responsible clinical investigator for the SARKOMTEST-study, a study focusing on the development of plasma-based biomarkers for disease detection and monitoring in patients with sarcomas.